Parkinson-Syndrom

Autor: Schrader, Ch.

Publikováno v: In Differenzialdiagnostik und Differenzialtherapie in der Inneren Medizin Edition: Second Edition. 2018:192-193

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.

Autor: Schrader CH; Section Experimental and Translational Head and Neck Oncology, Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany. carola.h.schrader@web.de., Kolb M; Section Experimental and Translational Head and Neck Oncology, Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany. markus.kolb@med.uni-heidelberg.de., Zaoui K; Section Experimental and Translational Head and Neck Oncology, Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany. karim.zaoui@med.uni-heidelberg.de., Flechtenmacher C; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. christa.flechtenmacher@med.uni-heidelberg.de., Grabe N; Hamamatsu Tissue Imaging and Analysis Center (TIGA), BIOQUANT, Heidelberg, Germany. niels.grabe@bioquant.uni-heidelberg.de.; Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany. niels.grabe@bioquant.uni-heidelberg.de., Weber KJ; Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany. klaus-josef.weber@med.uni-heidelberg.de., Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany. t.hielscher@Dkfz-Heidelberg.de., Plinkert PK; Section Experimental and Translational Head and Neck Oncology, Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany. peter.plinkert@med.uni-heidelberg.de., Hess J; Section Experimental and Translational Head and Neck Oncology, Department of Otolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany. j.hess@dkfz.de.; Research Group Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany. j.hess@dkfz.de.

Publikováno v: Molecular cancer [Mol Cancer] 2015 May 20; Vol. 14, pp. 107. Date of Electronic Publication: 2015 May 20.